Home › Dermatomyositis › Connecticut › New Haven
Dermatomyositis clinical trials in New Haven, CT
3 studies for Dermatomyositis are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
RecruitingPhase 3
- Research Site, New Haven
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Rheumatology Patient Registry and Biorepository
RecruitingObservational studyHealthy volunteers welcome
- Yale New Haven Hospital, New Haven
Dermatomyositis trials in other cities
- Durham, NC8 studies
- Washington, DC7 studies
- New York City, NY5 studies
- Pittsburgh, PA5 studies
- Houston, TX5 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Baltimore, MD4 studies
- Miami, FL4 studies
- Cleveland, OH3 studies
- Aurora, CO3 studies
- Kansas City, KS3 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Opioid Overdose18 studies
- Alcohol Use Disorder (AUD)17 studies
- Acute Myeloid Leukemia17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.